![Stocks To Watch Today (23 Apr 2024): Gallantt Metal Hits New All-Time High, TECHNOE Brews 52-Week High & More](https://stockpricearchive.com/wp-content/uploads/2024/04/tue-23-apr-2024-stocks-to-watch-150x150.webp)
Home / Share Price Target / Lincoln
Lincoln Pharmaceuticals Share Price Target 2024, 2025, 2026 to 2039 With Charts
Lincoln Pharmaceuticals Limited | |||
![]() | Symbol: LINCOLN | ||
Price: ₹772.79 | |||
Exchange: NSE | |||
Healthcare -> Drug Manufacturers—Specialty & Generic |
Show Table of Contents
Table of Contents
- 1: Lincoln Pharmaceuticals Brief Company Overview
- 1.1: Lincoln Pharmaceuticals Limited: A Renowned Pharmaceutical Manufacturer
- 1.2: Lincoln Pharmaceuticals Financial Performance
- 1.2.1: Is Lincoln Pharmaceuticals A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Lincoln Pharmaceuticals Share Price Target For 2024
- 2.1.1: Lincoln Pharmaceuticals Share Price Target Table For 2024
- 2.1.2: Summary: Lincoln Pharmaceuticals Share Price Prediction For 2024
- 2.2: Lincoln Pharmaceuticals Share Price Target For 2025
- 2.2.1: Lincoln Pharmaceuticals Share Price Target Table For 2025
- 2.2.2: Summary: Lincoln Pharmaceuticals Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Lincoln Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Lincoln Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Lincoln Pharmaceuticals Past Performance
Lincoln Pharmaceuticals Brief Company Overview
Lincoln Pharmaceuticals Limited: A Renowned Pharmaceutical Manufacturer
Lincoln Pharmaceuticals Limited, established in 1979, is a leading pharmaceutical manufacturer based in India. The company has a strong global presence, providing a wide range of pharmaceutical products in various therapeutic areas.
Diverse Product Portfolio: Lincoln Pharmaceuticals boasts a comprehensive product range, including cough and cold medications, ophthalmic products, anti-malarial drugs, vitamins and minerals, anti-bacterial, anti-viral, and anti-fungal medications, analgesics, anti-psychotics, cardiovascular drugs, gastrointestinal products, and dermatological preparations. It also offers branded generics.
Commitment to Quality: Lincoln Pharmaceuticals is committed to providing high-quality pharmaceutical products. The company has a strong focus on research and development, ensuring its products meet the highest industry standards.
Reputation and Innovation: Over the years, Lincoln Pharmaceuticals has established a strong reputation in the pharmaceutical industry. The company is known for its innovation, quality standards, and commitment to patient health. It continues to explore new therapeutic areas and develop innovative products.
Advertisement
Lincoln Pharmaceuticals Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 1,548.09 Crore | Market valuation of Lincoln Pharmaceuticals's shares. |
Revenue (TTM) | 592.21 Crore | Total revenue generated by Lincoln Pharmaceuticals over the past twelve months. |
Net Income (TTM) | +97.96 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | 13.24% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | 16.54% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) | +8.6% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) | +24.5% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio | 0.18 | Company's total debt divided by total shareholder equity. |
Total Debt | 1.06 Crore | Sum of Lincoln Pharmaceuticals's current & long-term financial obligations. |
Total Cash | 152.74 Crore | Total amount of liquid funds available to Lincoln Pharmaceuticals. |
Beta | 0.72 | Beta is less than 1 indicating that the Lincoln Pharmaceuticals's price is less volatile than the market. |
Is Lincoln Pharmaceuticals A Good Buy For Long Term?
No valid response content found
To predict the Lincoln Pharmaceuticals's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Lincoln Pharmaceuticals Share Price Target For 2024
![Lincoln Pharmaceuticals Targets For 2024 Chart](/wp-content/uploads/nip_uploads/charts/lincoln_thisyear_20240907.webp)
The line chart displays the monthly closing prices of Lincoln Pharmaceuticals with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Lincoln Pharmaceuticals shares in 2024, see the table below.
Advertisement
Lincoln Pharmaceuticals Share Price Target Table For 2024
Lincoln Pharmaceuticals's Levels | Value | Reason/Importance |
---|---|---|
2024 Target 3 | 823.91 (+6.61%) | Price Action: Chart |
2024 Target 2 | 808.55 (+4.62%) | Price Action: Chart |
2024 Target 1 | 800.54 (+3.59%) | Fibonacci Extension Level 100% |
Current Price | 772.79 | Lincoln Pharmaceuticals's 1 share price as of Fri 06 Sep 2024 |
Stop Loss 1 | 755.90 (-2.19%) | Price Action: Sep 2024 Low |
Stop Loss 2 | 744.94 (-3.61%) | Fibonacci Retracement Level 38.2% |
Stop Loss 3 | 728.95 (-5.68%) | Price Action: 23 Aug 2024 High |
Summary: Lincoln Pharmaceuticals Share Price Prediction For 2024
In summary, Lincoln Pharmaceuticals has surged by ₹163.29, achieving a notable +26.79% increase from 1st January 2024 to 06 Sep 2024. Our analysis of Lincoln Pharmaceuticals for 2024 predicts an additional rise of 3.59% to 6.61% by the end of 2024 with three potential targets T1: 800.54, T2: 808.55, T3: 823.91. Stop Loss at SL1: 755.90, SL2: 744.94, SL3: 728.95.
Lincoln Pharmaceuticals has a 52-week high of ₹803.29, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹472.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Lincoln Pharmaceuticals.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Lincoln Pharmaceuticals Share Price Target For 2025
![Lincoln Pharmaceuticals Targets For 2025 Chart](/wp-content/uploads/nip_uploads/charts/lincoln_nextyear_20240907.webp)
The line chart displays the monthly closing prices of Lincoln Pharmaceuticals with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Lincoln Pharmaceuticals shares in 2025, see the table below.
Advertisement
Lincoln Pharmaceuticals Share Price Target Table For 2025
Lincoln Pharmaceuticals's Levels | Value | Reason/Importance |
---|---|---|
2025 Target 3 | 1068.26 (+38.23%) | Price Action: Chart |
2025 Target 2 | 1048.34 (+35.65%) | Price Action: Chart |
2025 Target 1 | 1037.96 (+34.31%) | Custom Fibonacci Extension Lvl 64.9% |
Current Price | 772.79 | Lincoln Pharmaceuticals's 1 share price as of Fri 06 Sep 2024 |
Stop Loss 1 | 711.59 (-7.92%) | Price Action: 29 Aug 2024 High |
Stop Loss 2 | 702.90 (-9.05%) | Price Action: 02 Sep 2024 Low |
Stop Loss 3 | 694.50 (-10.14%) | Price Action: 08 Aug 2024 High |
Summary: Lincoln Pharmaceuticals Share Price Prediction For 2025
In summary, Lincoln Pharmaceuticals has surged by ₹163.29, achieving a notable +26.79% increase from 1st January 2024 to 06 Sep 2024. Our analysis of Lincoln Pharmaceuticals for 2025 predicts an additional rise of 34.31% to 38.23% by the end of 2025 with three potential targets T1: 1037.96, T2: 1048.34, T3: 1068.26. Stop Loss at SL1: 711.59, SL2: 702.90, SL3: 694.50.
Lincoln Pharmaceuticals has a All-Time high of ₹804.45, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹472.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Lincoln Pharmaceuticals, we have created a specific page for that check here: Lincoln Pharmaceuticals Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Lincoln Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
![Lincoln Pharmaceuticals Targets Chart 2024, 2025, 2026 to 2039](/wp-content/uploads/nip_uploads/charts/lincoln_15years_20240907.webp)
This chart presents a detailed projection of Lincoln Pharmaceuticals share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 12.24% over the next 15 years.
For complete year by year Lincoln Pharmaceuticals long term share price target from 2024, 2025 to 2039 check the below table.
Lincoln Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
Year | Lincoln Pharmaceuticals Target | YoY Change % |
---|---|---|
2024 | ₹772.79 | [Current Price] |
2024 | ₹771.53 | -0.17% |
2025 | ₹984.06 | 27.54% |
2026 | ₹1,201.73 | 22.11% |
2027 | ₹1,466.96 | 22.07% |
2028 | ₹1,574.89 | 7.35% |
2029 | ₹1,824.19 | 15.82% |
2030 | ₹2,038.85 | 11.76% |
2031 | ₹2,262.46 | 10.96% |
2032 | ₹2,567.5 | 13.48% |
2033 | ₹2,602.25 | 1.35% |
2034 | ₹2,876.85 | 10.55% |
2035 | ₹3,093.64 | 7.53% |
2036 | ₹3,323.18 | 7.41% |
2037 | ₹3,668.05 | 10.37% |
2038 | ₹3,629.62 | -1.05% |
2039 | ₹3,884.74 | 7.02% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Lincoln Pharmaceuticals Past Performance
![LINCOLN main](/wp-content/uploads/nip_uploads/charts/LINCOLN_main.webp)
- In 2005, Lincoln Pharmaceuticals opening price was ₹44.2
- As of Fri 06 Sep 2024 the price stands at ₹772.79.
- This represents a Compound Annual Growth Rate (CAGR) of 15.38%.
- In 19 years, an investment of 10,000 would have become ₹1.74 Lakh.
As we wrap up, we hope you like our study on Lincoln Pharmaceuticals share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Lincoln Pharmaceuticals Share Price History
- Lincoln Pharmaceuticals Price Target Tomorrow
- Lincoln Pharmaceuticals Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.